Galectin Therapeutics Inc. (GALT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 03:30PM EDT. Market open.
| Previous Close | 3.5000 |
| Open | 3.5100 |
| Bid | 3.4400 x 100 |
| Ask | 3.4800 x 100 |
| Day's Range | 3.2500 - 3.5400 |
| 52 Week Range | 1.2800 - 4.2700 |
| Volume | |
| Avg. Volume | 161,972 |
| Market Cap | 214.187M |
| Beta (5Y Monthly) | 0.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Galectin Therapeutics Inc (GALT) Reports 2023 Financial Results and Business Developments
Comparing GALT's Performance Against Analyst Estimates and Exploring Future Prospects
- Simply Wall St.
Retail investors account for 55% of Galectin Therapeutics Inc.'s (NASDAQ:GALT) ownership, while insiders account for 21%
Key Insights Galectin Therapeutics' significant retail investors ownership suggests that the key decisions are...
- Simply Wall St.
Galectin Therapeutics Inc. (NASDAQ:GALT) surges 16%; individual investors who own 59% shares profited along with insiders
Key Insights Significant control over Galectin Therapeutics by individual investors implies that the general public has...
© 2024 Yahoo. All rights reserved.